Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HC41
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 118 | 122 | PF00656 | 0.415 |
CLV_C14_Caspase3-7 | 373 | 377 | PF00656 | 0.286 |
CLV_MEL_PAP_1 | 311 | 317 | PF00089 | 0.313 |
CLV_NRD_NRD_1 | 136 | 138 | PF00675 | 0.387 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.683 |
CLV_PCSK_KEX2_1 | 175 | 177 | PF00082 | 0.735 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.683 |
CLV_PCSK_PC1ET2_1 | 175 | 177 | PF00082 | 0.529 |
CLV_PCSK_SKI1_1 | 188 | 192 | PF00082 | 0.659 |
CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.530 |
CLV_Separin_Metazoa | 130 | 134 | PF03568 | 0.604 |
DEG_SPOP_SBC_1 | 32 | 36 | PF00917 | 0.526 |
DOC_CYCLIN_yCln2_LP_2 | 354 | 360 | PF00134 | 0.579 |
DOC_MAPK_gen_1 | 137 | 144 | PF00069 | 0.347 |
DOC_MAPK_gen_1 | 7 | 14 | PF00069 | 0.586 |
DOC_MAPK_MEF2A_6 | 137 | 146 | PF00069 | 0.444 |
DOC_MAPK_MEF2A_6 | 7 | 14 | PF00069 | 0.621 |
DOC_MAPK_NFAT4_5 | 7 | 15 | PF00069 | 0.634 |
DOC_PP2B_LxvP_1 | 12 | 15 | PF13499 | 0.594 |
DOC_PP2B_LxvP_1 | 354 | 357 | PF13499 | 0.531 |
DOC_PP4_FxxP_1 | 328 | 331 | PF00568 | 0.547 |
DOC_USP7_MATH_1 | 153 | 157 | PF00917 | 0.502 |
DOC_USP7_MATH_1 | 246 | 250 | PF00917 | 0.634 |
DOC_WW_Pin1_4 | 249 | 254 | PF00397 | 0.723 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.496 |
LIG_14-3-3_CanoR_1 | 294 | 301 | PF00244 | 0.559 |
LIG_14-3-3_CanoR_1 | 314 | 321 | PF00244 | 0.479 |
LIG_14-3-3_CanoR_1 | 48 | 58 | PF00244 | 0.529 |
LIG_BIR_III_2 | 121 | 125 | PF00653 | 0.352 |
LIG_BRCT_BRCA1_1 | 231 | 235 | PF00533 | 0.382 |
LIG_BRCT_BRCA1_1 | 297 | 301 | PF00533 | 0.561 |
LIG_Clathr_ClatBox_1 | 226 | 230 | PF01394 | 0.580 |
LIG_EVH1_2 | 57 | 61 | PF00568 | 0.266 |
LIG_FHA_1 | 178 | 184 | PF00498 | 0.736 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.524 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.603 |
LIG_FHA_2 | 167 | 173 | PF00498 | 0.738 |
LIG_FHA_2 | 371 | 377 | PF00498 | 0.468 |
LIG_FHA_2 | 65 | 71 | PF00498 | 0.525 |
LIG_LIR_Apic_2 | 325 | 331 | PF02991 | 0.547 |
LIG_LIR_Apic_2 | 344 | 348 | PF02991 | 0.330 |
LIG_LIR_Gen_1 | 91 | 100 | PF02991 | 0.504 |
LIG_LIR_Nem_3 | 91 | 97 | PF02991 | 0.455 |
LIG_MYND_1 | 41 | 45 | PF01753 | 0.542 |
LIG_REV1ctd_RIR_1 | 289 | 298 | PF16727 | 0.506 |
LIG_SH2_CRK | 111 | 115 | PF00017 | 0.701 |
LIG_SH2_CRK | 193 | 197 | PF00017 | 0.398 |
LIG_SH2_CRK | 25 | 29 | PF00017 | 0.475 |
LIG_SH2_CRK | 285 | 289 | PF00017 | 0.482 |
LIG_SH2_CRK | 345 | 349 | PF00017 | 0.502 |
LIG_SH2_NCK_1 | 193 | 197 | PF00017 | 0.439 |
LIG_SH2_NCK_1 | 285 | 289 | PF00017 | 0.482 |
LIG_SH2_STAP1 | 105 | 109 | PF00017 | 0.504 |
LIG_SH2_STAT5 | 386 | 389 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.410 |
LIG_SH3_3 | 275 | 281 | PF00018 | 0.450 |
LIG_SH3_3 | 354 | 360 | PF00018 | 0.560 |
LIG_TRFH_1 | 345 | 349 | PF08558 | 0.622 |
LIG_TYR_ITIM | 283 | 288 | PF00017 | 0.483 |
LIG_WW_1 | 57 | 60 | PF00397 | 0.269 |
MOD_CDK_SPK_2 | 71 | 76 | PF00069 | 0.496 |
MOD_CK1_1 | 181 | 187 | PF00069 | 0.698 |
MOD_CK1_1 | 249 | 255 | PF00069 | 0.768 |
MOD_CK1_1 | 257 | 263 | PF00069 | 0.718 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.510 |
MOD_CK2_1 | 257 | 263 | PF00069 | 0.734 |
MOD_CK2_1 | 64 | 70 | PF00069 | 0.418 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.501 |
MOD_GlcNHglycan | 116 | 120 | PF01048 | 0.531 |
MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.574 |
MOD_GlcNHglycan | 208 | 211 | PF01048 | 0.616 |
MOD_GlcNHglycan | 259 | 262 | PF01048 | 0.766 |
MOD_GlcNHglycan | 297 | 300 | PF01048 | 0.527 |
MOD_GlcNHglycan | 315 | 318 | PF01048 | 0.479 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.432 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.393 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.778 |
MOD_GSK3_1 | 255 | 262 | PF00069 | 0.738 |
MOD_GSK3_1 | 270 | 277 | PF00069 | 0.594 |
MOD_GSK3_1 | 290 | 297 | PF00069 | 0.199 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.390 |
MOD_N-GLC_1 | 147 | 152 | PF02516 | 0.570 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.426 |
MOD_NEK2_1 | 146 | 151 | PF00069 | 0.488 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.419 |
MOD_NEK2_1 | 295 | 300 | PF00069 | 0.501 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.493 |
MOD_NEK2_1 | 379 | 384 | PF00069 | 0.443 |
MOD_NEK2_1 | 46 | 51 | PF00069 | 0.533 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.411 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.485 |
MOD_PKA_1 | 137 | 143 | PF00069 | 0.330 |
MOD_PKA_2 | 313 | 319 | PF00069 | 0.506 |
MOD_Plk_1 | 115 | 121 | PF00069 | 0.668 |
MOD_Plk_1 | 8 | 14 | PF00069 | 0.637 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.434 |
MOD_Plk_4 | 153 | 159 | PF00069 | 0.367 |
MOD_Plk_4 | 274 | 280 | PF00069 | 0.587 |
MOD_Plk_4 | 33 | 39 | PF00069 | 0.536 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.378 |
MOD_ProDKin_1 | 249 | 255 | PF00069 | 0.725 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.508 |
MOD_SUMO_rev_2 | 139 | 145 | PF00179 | 0.545 |
TRG_DiLeu_BaEn_1 | 13 | 18 | PF01217 | 0.586 |
TRG_ENDOCYTIC_2 | 223 | 226 | PF00928 | 0.552 |
TRG_ENDOCYTIC_2 | 25 | 28 | PF00928 | 0.482 |
TRG_ENDOCYTIC_2 | 285 | 288 | PF00928 | 0.480 |
TRG_ER_diArg_1 | 6 | 8 | PF00400 | 0.681 |
TRG_Pf-PMV_PEXEL_1 | 8 | 13 | PF00026 | 0.649 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE21 | Leptomonas seymouri | 58% | 86% |
A0A0S4INY1 | Bodo saltans | 32% | 85% |
A0A1X0NGS9 | Trypanosomatidae | 37% | 100% |
A0A3R7NCH6 | Trypanosoma rangeli | 36% | 100% |
A0A3S5H694 | Leishmania donovani | 82% | 99% |
A4HTQ4 | Leishmania infantum | 82% | 99% |
C9ZPG1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9AMJ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |
Q4QI48 | Leishmania major | 82% | 100% |
V5BEE3 | Trypanosoma cruzi | 35% | 100% |